Skip to search formSkip to main contentSkip to account menu

Flavoxate

Known as: 2-Piperidinoethyl 3-methylflavone-8-carboxylate, 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester, 2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate 
A synthetic parasympatholytic with antimuscarinic, muscle relaxant and urinary antispasmodic properties. Flavoxate binds and inhibits muscarinic… 
National Institutes of Health

Related topics

Related topics

21 relations

Narrower (6)

3-methylflavone-8-carboxylic acidFlavoxate HydrochlorideSpasuretUrispas
Esophageal AchalasiaGastric outlet obstructionGastrointestinal HemorrhageIn Blood

Broader (2)

ParasympatholyticsUrological Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice.
Highly Cited
2015
Highly Cited
2015
Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.
BACKGROUND Pharmacotherapy constitutes an important adjunct to behavioral therapy for the treatment of overactive bladder (OAB… 
Highly Cited
2012
Highly Cited
2012
Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience
Study Type – Therapy (prevalence) 
Review
2002
Review
2002
Drug Therapy of Urinary Urge Incontinence: A Systematic Review
Review
2002
Review
2002
Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis.
BACKGROUND Chronic radiation cystitis occurs a minimum of three months after completion of pelvic radiotherapy and represents a… 
Review
2000
Review
2000
Interstitial cystitis. Etiology, diagnosis, and treatment.
  • J. Nickel
  • Canadian family physician Medecin de famille…
  • 2000
  • Corpus ID: 16018712
OBJECTIVE To review current knowledge about the epidemiology, etiology, diagnosis, and treatment of interstitial cystitis, with… 
1996
1996
Mechanisms of the Suppression of the Bladder Activity by Flavoxate
  • Y. KimuraY. Sasaki Osamu Nishizawa
  • International journal of urology
  • 1996
  • Corpus ID: 24393115
Background: This study was designed to clarify the primary site of action of flavoxate, clinically used for the treatment of… 
Highly Cited
1990
Highly Cited
1990
Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability.
Detrusor instability occurs in approximately 10% of the adult population, producing troublesome symptoms. The pharmacotherapy… 
Review
1989
Review
1989
Vesicoureteral reflux and voiding dysfunction: a prospective study.
  • H. Seruca
  • Journal of Urology
  • 1989
  • Corpus ID: 22152579
1979
1979
Effect of flavoxate on hyperactive detrusor muscle.
The effect of Flavoxate on hyperactive detrusor contraction was studied in 37 patients, including 11 patients in whom the drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)